Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Electromed | ELMD | Apr 26, 2024 | 15.77 | -2.53 |
Electronic Arts | EA | Apr 26, 2024 | 127.90 | +0.46 |
Electrovaya | ELVA | Apr 26, 2024 | 3.23 | +7.31 |
Eledon Pharmaceuticals | ELDN | Apr 26, 2024 | 2.06 | +1.98 |
Element Solutions | ESI | Apr 26, 2024 | 23.85 | +0.72 |
Elevai Labs | ELAB | Apr 26, 2024 | 0.66 | -2.20 |
Elevance Health | ELV | Apr 26, 2024 | 537.26 | -0.45 |
Elevation Oncology | ELEV | Apr 26, 2024 | 3.62 | -0.69 |
Eli Lilly | LLY | Apr 26, 2024 | 733.51 | +1.19 |
Elicio Therapeutics | ELTX | Apr 26, 2024 | 8.99 | -1.21 |
Eliem Therapeutics | ELYM | Apr 26, 2024 | 3.98 | +17.40 |
Ellington Financial | EFC | Apr 26, 2024 | 11.71 | +0.95 |
Ellington Financial | EFC-B | Apr 26, 2024 | 20.38 | -0.04 |
Ellington Financial A Pref | EFC-A | Apr 26, 2024 | 23.79 | -0.17 |
Ellington Financial D Pref | EFC-D | Apr 26, 2024 | 21.92 | 0.00 |
Ellington Financial E Pref | EFC-E | Apr 26, 2024 | 25.15 | -0.08 |
Ellington Financial Pref | EFC-C | Apr 26, 2024 | 23.32 | -0.13 |
Ellington Residential Mortgage REIT | EARN | Apr 26, 2024 | 6.76 | +0.60 |
Ellomay Capital | ELLO | Apr 26, 2024 | 14.68 | +1.17 |
Ellsworth Growth | ECF | Apr 26, 2024 | 7.74 | +0.58 |
Ellsworth Growth A | ECF-A | Apr 26, 2024 | 21.99 | 0.00 |
Elme Communities | ELME | Apr 26, 2024 | 15.04 | 0.00 |
Eltek | ELTK | Apr 26, 2024 | 10.90 | -2.42 |
Elutia | ELUT | Apr 26, 2024 | 2.78 | -3.81 |
Embecta | EMBC | Apr 26, 2024 | 10.31 | -0.87 |
Embotelladora Andina ADR | AKO-A | Apr 26, 2024 | 13.76 | +2.69 |
Embotelladora Andina ADR | AKO-B | Apr 26, 2024 | 16.70 | +0.78 |
Embrace Change Acquisition Unit | EMCGU | Apr 26, 2024 | 11.83 | 0.00 |
Embraer ADR | ERJ | Apr 26, 2024 | 25.99 | +3.96 |
EMCOR Group | EME | Apr 26, 2024 | 354.02 | +1.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.